Compare JPMorgan Ultra Short Income ETF (JPST) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Ultra Short Income ETF vs Rocket Lab USA Inc — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.3 (market cap $42.37B), while Rocket Lab USA Inc trades at $68.21 (market cap $43.74B). The key difference: JPMorgan Ultra Short Income ETF and Rocket Lab USA Inc are close in size by market cap, and Rocket Lab USA Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Ultra Short Income ETF for 47 Days and Rocket Lab USA Inc for 29 Days on average.
| JPST | RKLB | |
|---|---|---|
Market Cap | $42.37B | $43.74B |
Volume | 7,889,185 | 22,892,581 |
Sector | Fixed Income | Industrials |
52-Week High | $50.78 | $150.23 |
52-Week Low | $50.22 | $39.48 |
Typical Hold Time | 47 Days | 29 Days |
Enterprise Value | — | $41.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPST trades at $50.27 with no recent price movement, showing stability amid bearish technical signals from moving averages. The ETF maintains consistent dividend distributions of $0.17 monthly, positioning as a cash-equivalent alternative. Recent news highlights institutional position adjustments and growing investor interest in ultra-short income strategies as rates rise.
The outlook remains stable for income-focused investors seeking minimal volatility. Key risks include interest rate sensitivity and active management performance versus peers. Recent institutional selling activity suggests some profit-taking despite the fund's role in portfolio cash management strategies.
Rocket Lab (RKLB) trades at $68.40, down 4.89% amid a bearish technical signal. The company shows strong revenue growth with $602M in 2025 and $769M projected for 2026, though it remains unprofitable with a -21.51% net margin. Recent positive developments include securing its largest-ever commercial Electron launch contract with Synspective, expanding the backlog to over 100 missions. Analyst sentiment remains bullish with a $107 consensus price target despite current losses.
The outlook balances significant growth potential against persistent profitability challenges. Investment opportunity lies in Rocket Lab's expanding launch backlog and market position, while risks include intense competition from SpaceX, high valuation multiples, and ongoing cash burn. The stock's current technical weakness contrasts with strong fundamental growth prospects and Wall Street optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
